Ad
related to: suboxone controversy
Search results
Results from the WOW.Com Content Network
Buprenorphine/naloxone, sold under the brand name Suboxone among others, is a fixed-dose combination medication that includes buprenorphine and naloxone. [3] It is used to treat opioid use disorder , and reduces the mortality of opioid use disorder by 50% (by reducing the risk of overdose on full-agonist opioids such as heroin or fentanyl ).
Phil Lucas, a 32-year-old Suboxone patient, said he tried local NA meetings but no longer attends. “They acted like I was still a heroin addict basically,” he said, adding that people at the meetings kept asking him when he was going to get sober. Diana Sholler, 43, another Suboxone patient in Northern Kentucky, attends local AA meetings.
In December 2018, The New York Times published a critical article about Medication-Assisted Treatment applied by JourneyPure, which involves such drugs as buprenorphine (also known as Suboxone) or naltrexone (more commonly known as Vivitrol). The use of Medication-Assisted Treatment was acknowledged during the interview by Sam MacMaster, the co ...
The company's main products are Sublocade, Subutex and its Naloxone-combined preparation Suboxone, both substitution products for opioid addiction. [2] Other products include remedies for cocaine and opioid analgesic overdose and treatment for alcohol dependence: the company claims this to be the largest pipeline of addiction drugs in the world.
In the European Union, Subutex and Suboxone, buprenorphine's high-dose sublingual tablet preparations, were approved for opioid use disorder treatment in September 2006. [106] In the Netherlands, buprenorphine is a list II drug of the Opium Law, though special rules and guidelines apply to its prescription and dispensation. In France ...
Naltrexone therapy, which critics claim lacks long-term efficacy and can actually be detrimental to a patient's long-term recovery, has led to controversy. Additionally, there have been many questions raised about the ethics as well as safety of rapid detox following a number of deaths resulting from the procedure.
The Drug Trafficking Safe Harbor Elimination Act was a bill proposed to the 112th United States Congress in 2011. [1] It was introduced to amend Section 846 of the Controlled Substances Act to close a loophole that has allowed many drug trafficking conspirators to avoid federal prosecution.
The Lululemon controversy over 'certain customers' comment, explained. Sarah Lemire. Updated March 5, 2024 at 1:13 PM.
Ad
related to: suboxone controversy